Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001753926-25-001081·Friedberg Ezra M
Schedule 13D ownership disclosure
PELTHOS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 171126204
Event date: 2025-07-01
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ezra FriedbergReported CIK 0001679440
Shares: 250,121.00 · Class: 8.3%
- Balmoral Financial Group LLCReported CIK 0001988769
Shares: 92,072.00 · Class: 3.1%
- Key Recovery Group LLC
Shares: 40,000.00 · Class: 1.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-001081
- Form type
- SCHEDULE 13D/A
- Filer
- Friedberg Ezra M
- CIK
- CIK 1679440
- Filed
- Jul 03, 2025
- Reporting period
- Jul 01, 2025
- Description
- Schedule 13D beneficial ownership